Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate efficacy and safety of the combined oral contraceptive [COC] SH T00186D (0.02 mg ethinylestradiol [EE]; 3 mg drospirenone [DRSP]) applied in a conventional and an extended flexible regimen in the treatment of moderate to severe primary dysmenorrhea Primary efficacy variables: • Number of days with dysmenorrheic pain over 140 days of treatment
Critère d'inclusion
- women suffering from primary dysmenorrhea